International Clinical Trial: Sequencing Combined with Plasma Proteomics for Dissecting the Immuno: Molecular Signatures of Sepsis Acute Kidney Injury

Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119324) titled 'Sequencing Combined with Plasma Proteomics for Dissecting the Immuno: Molecular Signatures of Sepsis Acute Kidney Injury' on Feb. 25.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: Fuzhou University Affiliated Provincial Hospital

Condition: Sepsis-associated acute kidney injury

Intervention: sepsis without acute kidney injury group:N/A

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-02-25

Target Sample Size: sepsis without acute kidney injury group:356;sepsis with acute kidney injury group:356;

Countries of Recruitment: China

To know more...